Answers are grounded in this paper and cite their sources.
Population aging has prompted growing interest in strategies to mitigate age-related functional decline. In this study, selenium-containing egg white peptides (SeC-EP) were evaluated in a D-galactose-induced senescence-like mouse model and directly compared with nonselenium egg white peptides, followed by prioritization of candidate peptide sequences. Optimized SeC-EP contained 0.71 ± 0.16 mg Se/kg. In animal experiments, SeC-EP increased Y-maze spontaneous alternation, novel object discrimination, and serum SOD activity by 28.75%, 59.06%, and 15.24%, respectively, while decreasing serum MDA, TNF-α, IL-6, and IL-1β by 46.02%, 36.80%, 47.55%, and 40.04% (p < 0.05). Consistently, treatment was associated with decreased hepatic Keap1 and increased Nrf2 and HO-1 protein expression. Subsequently, molecular docking prioritized SISPILGSC-SeC-AHRHLQ, YTAGVC-SeC-GLVPVMAE, IVC-SeC-GP, and TGPC-SeC-P, with binding energies of −9.1, −8.5, −8.2, and −8.1 kcal/mol. Finally, these peptides modulated Keap1, Nrf2, and HO-1 expression in H2O2-treated HEK-293T model. Collectively, SeC-EP attenuated multiple senescence-like abnormalities and provided candidate selenium-containing peptides for further validation.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: